文献速递重症综合管理与镇静镇痛

重症疾病长期生存者的有氧运动能力:post-EPaNIC随访研究的二次分析

Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study.
PubMed 文献 · Intensive Care Med · 2021-11-08
一句话结论ICU 5年生存者中37.7%有氧运动能力异常,常伴肌肉限制,且ICU期间器官衰竭严重程度(SOFA-max)与VO2peak独立相关。

该研究为EPaNIC随访队列(NCT00512122)的二次分析,纳入433例ICU入住后1至5年接受心肺运动试验(CPET)筛查的患者。5年ICU生存者(N=361)的运动能力与历史久坐人群及人口学匹配对照(N=49)比较;在完成极量CPET(呼吸交换率>1.05,N=313)的5年生存者中,以VO2peak<预测峰值85%(%predVO2peak)定义运动能力异常。结果显示运动能力异常在5年生存者中为118/313(37.7%),对照为1/48(2.1%),p<0.001;VO2peak生存者24.0±9.7 ml/min/kg vs 对照31.7±8.4 ml/min/kg,p<0.001;%predVO2peak生存者94%±31% vs 对照123%±25%,p<0.001。肌肉限制常参与5年时运动能力受损[71/118(60.2%)]。校正预定义混杂因素后,SOFA-max与随访期间VO2peak独立相关。结论提示重症生存者常有有氧运动能力异常,器官衰竭严重程度与这些损害独立相关。

要点

  • 5年ICU生存者中运动能力异常(%predVO2peak<85%)占118/313(37.7%),对照仅1/48(2.1%),p<0.001。
  • 5年生存者VO2peak低于对照:24.0±9.7 ml/min/kg vs 31.7±8.4 ml/min/kg,p<0.001。
  • 5年生存者%predVO2peak低于对照:94%±31% vs 123%±25%,p<0.001。
  • 运动能力受损者中肌肉限制常见:71/118(60.2%)。
  • ICU期间SOFA-max与随访期间VO2peak独立相关(校正预定义混杂因素后)。

适用人群与场景

  • EPaNIC随访队列(NCT00512122)中ICU入住后1至5年接受CPET筛查的433例患者。
  • 5年ICU生存者(N=361),其中完成极量CPET(呼吸交换率>1.05)者N=313。
  • 人口学匹配对照(N=49),其中完成极量CPET者N=48。

诊断标准与关键阈值

  • 极量CPET定义:呼吸交换率>1.05。
  • 运动能力异常定义:VO2peak<预测峰值摄氧量的85%(%predVO2peak<85%),基于历史久坐人群预测值。

研究设计与关键结果

  • 研究类型:EPaNIC随访队列(NCT00512122)的二次分析;纳入433例ICU入住后1至5年接受CPET筛查的患者。
  • 运动能力异常:5年生存者118/313(37.7%)vs 对照1/48(2.1%),p<0.001。
  • VO2peak:5年生存者24.0±9.7 ml/min/kg vs 对照31.7±8.4 ml/min/kg,p<0.001。
  • %predVO2peak:5年生存者94%±31% vs 对照123%±25%,p<0.001。
  • 5年时运动能力受损者中肌肉限制参与:71/118(60.2%)。
  • SOFA-max(ICU期间最大序贯器官衰竭评估评分)与VO2peak独立相关,贯穿随访期;采用线性混合模型,校正预定义混杂因素并纳入所有随访CPET研究。

证据类型、等级与局限

  • 证据类型:EPaNIC随访队列(NCT00512122)的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • ICU 5年生存者常有有氧运动能力异常(37.7%),且肌肉限制常见(60.2%),提示评估长期生存者运动能力时应关注肌肉因素。
  • ICU期间SOFA-max越高,随访期间VO2peak越低(独立相关),提示器官衰竭严重程度可帮助识别远期运动能力受损高风险者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: To evaluate aerobic exercise capacity in 5-year intensive care unit (ICU) survivors and to assess the association between severity of organ failure in ICU and exercise capacity up to 5-year follow-up.

METHODS: Secondary analysis of the EPaNIC follow-up cohort (NCT00512122) including 433 patients screened with cardiopulmonary exercise testing (CPET) between 1 and 5 years following ICU admission. Exercise capacity in 5-year ICU survivors (N = 361) was referenced to a historic sedentary population and further compared to demographically matched controls (N = 49). In 5-year ICU survivors performing a maximal CPET (respiratory exchange ratio > 1.05, N = 313), abnormal exercise capacity was defined as peak oxygen consumption (VO2peak) < 85% of predicted peak oxygen consumption (%predVO2peak), based on the historic sedentary population. Exercise liming factors were identified. To study the association between severity of organ failure, quantified as the maximal Sequential Organ Failure Assessment score during ICU-stay (SOFA-max), and exercise capacity as assessed with VO2peak, a linear mixed model was built, adjusting for predefined confounders and including all follow-up CPET studies.

RESULTS: Exercise capacity was abnormal in 118/313 (37.7%) 5-year survivors versus 1/48 (2.1%) controls with a maximal CPET, p < 0.001. Aerobic exercise capacity was lower in 5-year survivors than in controls (VO2peak: 24.0 ± 9.7 ml/min/kg versus 31.7 ± 8.4 ml/min/kg, p < 0.001; %predVO2peak: 94% ± 31% versus 123% ± 25%, p < 0.001). Muscular limitation frequently contributed to impaired exercise capacity at 5-year [71/118 (60.2%)]. SOFA-max independently associated with VO2peak throughout follow-up.

CONCLUSIONS: Critical illness survivors often display abnormal aerobic exercise capacity, frequently involving muscular limitation. Severity of organ failure throughout the ICU stay independently associates with these impairments.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. Van Aerde N, Meersseman P, Debaveye Y, et al. Aerobic exercise capacity in long-term survivors of critical illness: secondary analysis of the post-EPaNIC follow-up study. Intensive Care Med. 2021. PMID: 34750648. doi:10.1007/s00134-021-06541-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。